Home/Filings/4/0001140361-21-033145
4//SEC Filing

Stanford Scott 4

Accession 0001140361-21-033145

CIK 0001628945other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 5:39 PM ET

Size

21.1 KB

Accession

0001140361-21-033145

Insider Transaction Report

Form 4
Period: 2021-09-28
Stanford Scott
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2021-09-28+9,619,4519,748,805 total(indirect: See Footnotes)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See Footnotes)
    Common Stock (1,092,329 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,834,0880 total(indirect: See Footnotes)
    Common Stock (3,834,088 underlying)
  • Conversion

    Series A Preferred Stock

    2021-09-285,450,8980 total(indirect: See Footnotes)
    Common Stock (5,450,898 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-283,076,2240 total(indirect: See Footnotes)
    Common Stock (3,076,224 underlying)
  • Conversion

    Common Stock

    2021-09-28+4,926,4175,120,448 total(indirect: See Footnotes)
  • Award

    Common Stock

    2021-09-28$12.80/sh+371,293$4,752,5505,491,741 total(indirect: See Footnotes)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-281,092,3290 total(indirect: See Footnotes)
    Common Stock (1,092,329 underlying)
Footnotes (6)
  • [F1]On September 28, 2021, the Series A Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F2]On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F3]On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F4]The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Scott Stanford is the sole managing member of ACME GP I and may be deemed to have voting and investment power with respect to the shares held by ACME I and as a result may be deemed to have beneficial ownership of such shares. The reporting person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
  • [F5]The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Scott Stanford is the sole managing member of ACME GP II and may be deemed to have voting and investment power with respect to the shares held by ACME II and as a result may be deemed to have beneficial ownership of such shares. The reporting person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
  • [F6]On September 28, 2021, outstanding principal and accrued interest underlying a convertible note automatically converted into Common Stock upon the closing of the initial public offering of the Issuer's common stock at a conversion price equal to 80% of the initial public offering price per share.

Issuer

Cue Health Inc.

CIK 0001628945

Entity typeother

Related Parties

1
  • filerCIK 0001866544

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 5:39 PM ET
Size
21.1 KB